Contraceptive Drugs Market
Contraceptive Drugs Market Size, Share & Trends Analysis Report by Product (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), by Age Group (15–24 years, 25–34 years, 35–44 years, Above 44 years), by End User (Homecare, Hospitals, Clinics), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)
Market Snapshot
| Contraceptive Drugs Market Forecast Year: | 2022 - 2028 |
| Contraceptive Drugs Market Historical Year: | 2016 - 2021 |
| Contraceptive Drugs Market 2021: | USD 12.1 Billion |
| Contraceptive Drugs Projected Market 2028: | USD 16.5 Billion |
| Contraceptive Drugs Market CAGR: | 5.4% |
| Fastest Growing Region: | Asia Pacific |
| Largest Region: | North America |
Global Contraceptive Drugs Market:
Contraceptive Drugs Market - By Product, Age Group, End User, and Region.
Market Synopsis:
Contraception is a method used to prevent unwanted pregnancies and reduce the risk of sexually transmitted infections aka STIs. Rising awareness for birth control and safe sex practices are expected to bolster the demand for Contraceptive Drugs across the world in the coming years. The increasing availability of sex education and rising focus on safe sex practices to avoid unwanted pregnancies are expected to aid Contraceptive Drugs Market growth over the coming years. Increased use of contraception in young women is expected to crucially shape Contraceptive Drugs Market potential across the forecast period.
The increasing availability of convenient and modern contraceptives and the high availability of preferred contraceptives are also expected to bolster the Contraceptive Drugs Market growth through 2028. However, health risks associated with prolonged use of Contraceptive Drugs are anticipated to have a constraining effect on the overall Contraceptive Drugs Market growth. The lockdown of 2020 led to a downfall of the Contraceptive Drugs Market as multiple sales channels were closed. However, the Contraceptive Drugs Market is expected to make a rapid recovery in the post-pandemic era as the world has now returned to normal and restrictions have been lifted.
Parameter
Details
Market Size Provided for Years
2016-2028
Base Year
2021
Historic Years
2016-2020
Forecast Years
2022-2028
Segments Covered
Region & Counties Covered
Companies Covered
Report Coverage
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
impact analysis
Market Segmentation:
The Global Contraceptive Drugs Market is segmented based on Product, Age Group, and End-User. Based on the End-User the market is segmented as Homecare, Hospitals, and Clinics. Based on Product, the market is segmented as Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives. Based on Age Group, the market is segmented as 15–24 years, 25–34 years, 35–44 years, and Above 44 years.
Based on End-user:
Based on End-user, the market is segmented as Homecare, Hospitals, and Clinics. The Home Care segment accounts for a prominent market share. Increasing consumption of oral contraceptives to prevent STIs and unwanted pregnancies is expected to drive demand in this segment across the forecast period. Increased demand for after-intercourse contraceptives is also expected to favor the growth of the home care segment in the Global Contraceptive Drugs Market landscape through 2028.
Based on Product-
Based on Product, the market is segmented into Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives. The Oral Contraceptive Pills segment is anticipated to account for a dominant market share across the forecast period owing to the high preference for such contraceptives among consumers. The reversible nature of these contraceptives drives their popularity. High convenience and effectiveness are other factors that propel growth in this segment over the coming years. Injectable Contraceptives are anticipated to witness a rise in demand at a fast Compound Annual Growth Rate (CAGR) over the forecast period.
North America Accounts for a Dominant Market Share
Based on all the regions, the North American region is expected to lead the Global Contraceptive Drugs Marketplace. The presence of developed healthcare infrastructure, adequate sex education, high availability of Contraceptive Drugs, and high consumer spending potential are major factors that influence the Contraceptive Drugs Market potential in this region. The high prevalence of STIs is also expected to boost the adoption of contraceptives in this region. The United States is anticipated to account for a significant market share in the North American market. The region held a market share of 45.1% in 2021 and was valued at USD 5.4 billion. The demand for Contraceptive Drugs is expected to rise fastest in the Asia Pacific region owing to increasing awareness for contraceptives and government initiatives to boost the same.
The key players in the Global Contraceptive Drugs Market include- Agile Therapeutics, Allergan PLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Piramal Healthcare, Mylan N.V., Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd. and others.
Segmentation of the Global Contraceptive Drugs Market:
Research Methodology: Contraceptive Drugs Market by Product by Age Group by End User by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
The later stage covers data validation and collection from primary research. The information gained/procured from the secondary data sources is validated through extensive primary interviews with industry experts across the Contraceptive Drugs supply chain. The primary research is also conducted to identify key players in the market and to gather and validate already procured information pertaining to their market-specific financial information. Moreover, primary research is used to gain/validate information about:
- Contraceptive Drugs market size at regional and country level
- Key industry players and their market share and Contraceptive Drugs market-specific sales/revenue
- Understanding of the Contraceptive Drugs supply chain and overall ecosystem
Data Triangulation and Market Size Estimations
After arriving at the global market numbers, top-down and bottom-up approaches are used to estimate, validate and finalize the market size of the Contraceptive Drugs market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. During the data triangulation process, the data was analyzed by employing various data models and statistical techniques to arrive at exact statistics and market size for each segment/sub-segment of the market. The data is analyzed and triangulated by considering all the key market impacting factors from both supply and demand side of Contraceptive Drugs market.
Frequently Asked Questions
-
What is
the global demand for Contraceptive Drugs
in terms of revenue?
The global Contraceptive Drugs valued at USD 12.1 Billion in 2020 and is expected to reach USD 16.5 Billion in 2028 growing at a CAGR of 5.4%
-
Which
are the prominent players
in the market?
The prominent players in the market are Agile Therapeutics, Allergan PLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Piramal Healthcare, Mylan N.V., Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd..
-
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 5.4% between 2021 and 2028.
-
What are
the driving factors
fueling the growth of the market.
The driving factors of the Contraceptive Drugs include
- Rise in need for preventing unwanted pregnancy
-
Which
region accounted for the
largest share in the market?
North America was the leading regional segment of the Contraceptive Drugs in 2020.
Choose License
Our Companies
